Table 2.

Within trial dose allocation

Patient	Group	$d_1^{max}$	$d_2^{max}$	$d_3^{max}$	Dose allocated	DLT
1	3 (most frail)	-	-	-	1	no
2	2 (less frail)	-	-	1	2	no
3	2 (less frail)	-	2	1	3	no
4	3 (most frail)	-	3	1	2	no
5	1 (less frail)	-	3	2	4	yes

End stage 1. Begin stage 2 modeling.